These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37580752)

  • 21. The Role of the Private Sector in the COVID-19 Pandemic: Experiences From Four Health Systems.
    Wallace LJ; Agyepong I; Baral S; Barua D; Das M; Huque R; Joshi D; Mbachu C; Naznin B; Nonvignon J; Ofosu A; Onwujekwe O; Sharma S; Quayyum Z; Ensor T; Elsey H
    Front Public Health; 2022; 10():878225. PubMed ID: 35712320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organizational Characteristics Associated With Fundraising Performance of Nonprofit Hospitals.
    Erwin CO; Landry AY
    J Healthc Manag; 2015; 60(2):96-112. PubMed ID: 26529846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Industry-academic partnerships: an approach to accelerate innovation.
    Chen J; Pickett T; Langell A; Trane A; Charlesworth B; Loken K; Lombardo S; Langell JT
    J Surg Res; 2016 Sep; 205(1):228-33. PubMed ID: 27621024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From spare change to real change. The social sector as beta site for business innovation.
    Kanter RM
    Harv Bus Rev; 1999; 77(3):122-32, 210. PubMed ID: 10387574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The public-private partnership in medical services market].
    Abubakirov AS; Zudin AB; Snegireva YY
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2019 Nov; 27(6):953-958. PubMed ID: 31884748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Building and Sustaining Effective Partnerships for Training the Next Generation of Global Health Leaders.
    Nakanjako D; Kendall D; Sewankambo NK; Razak MH; Oduor B; Odero T; Garcia P; Farquhar C
    Ann Glob Health; 2021; 87(1):66. PubMed ID: 34307069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conceptual framework for analysing partnership and synergy in a global health alliance: case of the UK Public Health Rapid Support Team.
    Raftery P; Hossain M; Palmer J
    Health Policy Plan; 2022 Mar; 37(3):322-336. PubMed ID: 34919688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
    Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
    Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Contextual Factors in Private Sector Engagement: A Case Study of Private Sector Contribution to COVID-19 Mitigation in Nigeria.
    Okeke C; Eigbiremolen GO; Uzochukwu B; Mbachu C; Onwujekwe O
    Front Public Health; 2022; 10():915330. PubMed ID: 35801254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An innovative and integrated model for global outbreak response and research - a case study of the UK Public Health Rapid Support Team (UK-PHRST).
    Raftery P; Hossain M; Palmer J
    BMC Public Health; 2021 Jul; 21(1):1378. PubMed ID: 34247621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Science Translation During the COVID-19 Pandemic: An Academic-Public Health Partnership to Assess Capacity Limits in California.
    Maldonado P; Peng A; Ouyang D; Suckale J; Ho DE
    Am J Public Health; 2022 Feb; 112(2):308-315. PubMed ID: 35080959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea.
    Park J; Chung E
    World Dev; 2021 Jan; 137():105198. PubMed ID: 32982017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Global Burden of Disease 2020 Health Financing Collaborator Network
    Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partnerships for better neglected disease drug discovery and development: how have we fared?
    Sunyoto T
    Expert Opin Drug Discov; 2020 May; 15(5):531-537. PubMed ID: 32129688
    [No Abstract]   [Full Text] [Related]  

  • 37. Does public health policy quality foster state innovation capacity? Evidence from a global panel data.
    Ji X; Gao L; Liu H; He S; Zhu B; Chow C; Chen J; Lu Z; Li L
    Front Public Health; 2022; 10():952842. PubMed ID: 36438285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global strategic partnerships in regenerative medicine.
    French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA
    Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PFI redux? Assessing a new model for financing hospitals.
    Hellowell M
    Health Policy; 2013 Nov; 113(1-2):77-85. PubMed ID: 24138730
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.